Zhang Tao, Jiang Jingjing, Lyu Xiaofeng, Xu Xian, Wang Shuqi, Liu Zijian, Yin Jianhai, Li Weidong
Anhui Provincial Center for Disease Control and Prevention, Hefei, Anhui Province, China.
National Institute of Parasitic Diseases, Chinese Center for Disease Control and Prevention (Chinese Center for Tropical Diseases Research), National Health Commission Key Laboratory of Parasite and Vector Biology; WHO Collaborating Center for Tropical Diseases; National Center for International Research on Tropical Diseases, Shanghai, China.
China CDC Wkly. 2022 Jul 15;4(28):622-625. doi: 10.46234/ccdcw2022.135.
WHAT IS ALREADY KNOWN ABOUT THIS TOPIC?: China was certified malaria-free on June 30, 2021. However, imported malaria continuously threatens the effort to prevent re-establishment of malaria in China.
WHAT IS ADDED BY THIS REPORT?: Measures such as international travel restrictions, entry quarantine, and screening in fever clinics during the coronavirus disease 2019 (COVID-19) period were associated with a significant decrease of imported malaria cases in Anhui Province, a higher proportion of non- (non-) malaria reported infections, and a higher proportion of cases requiring medical attention at their initial visit.
WHAT ARE THE IMPLICATIONS FOR PUBLIC HEALTH PRACTICES?: It is necessary to be vigilant about imported malaria during the COVID-19 epidemic, especially for non- infections which are more difficult to detect, and to promote research, development, and introduction of more sensitive and specific point-of-care detection methods for non- species.
关于该主题已知的信息有哪些？：中国于2021年6月30日被认证为疟疾消除国家。然而，输入性疟疾持续威胁着中国预防疟疾重新传播的努力。
本报告新增了哪些内容？：在2019冠状病毒病（COVID-19）期间采取的国际旅行限制、入境检疫和发热门诊筛查等措施，与安徽省输入性疟疾病例显著减少、非（非）疟原虫感染报告比例较高以及初次就诊时需要医疗救治的病例比例较高有关。
对公共卫生实践有哪些启示？：在COVID-19疫情期间有必要对输入性疟疾保持警惕，尤其是对于更难检测的非疟原虫感染，并促进针对非疟原虫种类的更灵敏、特异的即时检测方法的研发和引入。
